Cambridge, MA, United States of America

Aaron D Edwards

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Beam Therapeutics Inc., Ucl Business Plc. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aaron D Edwards. Retrieved from https://idiyas.com/inventor/aaron-d-edwards

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Aaron D. Edwards

Introduction

Aaron D. Edwards is a notable inventor based in Cambridge, MA (US). He has made significant strides in the field of medical research, particularly in the treatment of liquid cancers. His work focuses on enhancing the capabilities of immune cells to combat neoplasia effectively.

Latest Patents

Aaron D. Edwards holds a patent for "Compositions and methods for treatment of liquid cancers." This invention features genetically modified immune cells that possess enhanced anti-neoplasia activity, resistance to immune suppression, and a decreased risk of eliciting a graft versus host reaction. The patent also outlines methods for producing and utilizing these modified immune effector cells.

Career Highlights

Throughout his career, Edwards has worked with prominent companies such as UCL Business Plc and Beam Therapeutics Inc. His contributions to these organizations have been instrumental in advancing research and development in the field of cancer treatment.

Collaborations

Some of his notable coworkers include Jason Michael Gehrke and Waseem Qasim. Their collaborative efforts have further enriched the research environment in which Edwards operates.

Conclusion

Aaron D. Edwards is a pioneering inventor whose work in the treatment of liquid cancers showcases the potential of genetically modified immune cells. His contributions to the field are significant and continue to inspire advancements in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…